Publikationen, an denen er mitarbeitet ANTONIO PORTOLÉS PÉREZ (28)

2024

  1. Adverse drug reactions in paediatric surgery: prospective study on frequency and risk related factors

    BMC Pediatrics, Vol. 24, Núm. 1

  2. Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants

    iScience, Vol. 27, Núm. 9

2022

  1. Effect of Obesity and Roux-En-Y Gastric Surgery on Omeprazole Pharmacokinetics

    Obesity Facts, Vol. 15, Núm. 2, pp. 271-280

  2. Immune Response and Reactogenicity After Immunization With a Suboptimal Two-Dose mRNA Vaccine Followed by a Full Vaccination With a Standard mRNA Vaccine Compared to a Prime-Boost Regimen of a Standard mRNA Vaccine: A Multicenter Cohort Study

    SSRN Electronic Journal

  3. Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

    eClinicalMedicine, Vol. 51

2020

  1. Chiral bioanalytical methods in bioequivalence studies of intravenous vs. oral formulations of ibuprofen

    Chirality, Vol. 32, Núm. 9, pp. 1169-1177

  2. Effect of enantiomerism on the bioequivalence of a new ibuprofen 600-mg tablet formulation obtained by roller compaction

    Chirality, Vol. 32, Núm. 2, pp. 185-190

  3. La isoapariencia farmacéutica: un factor de riesgo de errores de medicación

    Metas de enfermería, Vol. 23, Núm. 7, pp. 7-15

2019

  1. Effect of Roux-en-Y gastric surgery on ciprofloxacin pharmacokinetics: an obvious effect?

    European Journal of Clinical Pharmacology, Vol. 75, Núm. 5, pp. 647-654

2016

  1. Adverse drug reactions in neonates: A prospective study

    Archives of Disease in Childhood, Vol. 101, Núm. 4, pp. 371-376

2012

  1. Response letter to Malafarina and colleagues

    Journal of the American Geriatrics Society

2011

  1. Risk of cerebrovascular accident associated with use of antipsychotics: Population-based case-control study

    Journal of the American Geriatrics Society, Vol. 59, Núm. 7, pp. 1182-1187

2009

  1. Truncated Area under the Urinary Excretion Rate Curve in the Evaluation of Alendronate Bioequivalence after a Single Dose in Healthy Volunteers

    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, Vol. 59, Núm. 8, pp. 397-402

  2. Truncated area under the urinary excretion rate curve in the evaluation of alendronate bioequivalence after a single dose in healthy volunteers

    Arzneimittel-Forschung/Drug Research, Vol. 59, Núm. 8, pp. 397-402

2007

  1. Effect of drug-test interactions on length of hospital stay

    Pharmacoepidemiology and Drug Safety, Vol. 16, Núm. 1, pp. 39-45

2006

  1. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections

    Revista Espanola de Quimioterapia, Vol. 19, Núm. 1, pp. 65-75

2005

  1. Bioequivalence study of two different tablet formulations of carvedilol in healthy volunteers

    Arzneimittel-Forschung/Drug Research, Vol. 55, Núm. 4, pp. 212-217

  2. Erratum: Bioequivalence study of two different tablet formulations of carvedilol in healthy volunteers (Arzneimittel-Forschung/Drug Research (2005) 55, 4 (212-217))

    Arzneimittel-Forschung/Drug Research

2004

  1. Bioequivalence study of two formulations of enalapril, at a single oral dose of 20 mg (tablets): A randomized, two-way, open-label, crossover study in healthy volunteers

    Current Therapeutic Research - Clinical and Experimental, Vol. 65, Núm. 1, pp. 34-46

2003

  1. A new high-absorption-rate paracetamol 500-mg formulation: A comparative bioavailability study in healthy volunteers

    Current Therapeutic Research - Clinical and Experimental, Vol. 64, Núm. 7, pp. 401-411